Latest Cancer: Kidney news
ASCO: Pembrolizumab Ups DFS in High-Risk Resected Clear-Cell RCC
posted June 4th
by modernClinician Editorial Team
by modernClinician Editorial Team
Occult Brain Mets Detected in Patients With Advanced Renal Cancer
posted May 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Nivolumab Plus Cabozantinib Tops Sunitinib for Renal Cell Carcinoma
posted March 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Lenvatinib Plus Pembrolizumab Tops Sunitinib in Advanced RCC
posted February 19th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Paternal Exposure to Valproate Not Linked to Offspring Neurodevelopmental Disorders 
Chemo-Free Combo of Four Targeted Therapies Shows Promise in Metastatic Breast Cancer 
Drug Retention in Spondyloarthritis Varies With Socioeconomic Status 
December 2024 to 2025 Saw Significant Increase in Leucovorin Dispensing Related Articles
Pembrolizumab-Belzutifan Tied to Improved Disease-Free Survival in Renal Cell Carcinoma 
Comparable Progression Risk Seen With Ablation Versus Surgery for T1a Renal Cell Carcinoma 
Incidence Rates Increased From 2003 to 2017 for Six Cancer Types in 42 Countries 
Global Burden of Renal Cancer Expected to Double by 2050 Monthly Specialist Briefings
Stay Connected
